Correction to: Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer

被引：0
|
作者：
Liqun Yang
Qian Lei
Lin Li
Jie Yang
Zhen Dong
Hongjuan Cui
机构：
[1] Southwest University,State Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology
[2] Southwest University,Cancer Center, Medical Research Institute
[3] Southwest University,Engineering Research Center for Cancer Biomedical and Translational Medicine
[4] Southwest University,Chongqing Engineering and Technology Research Center for Silk Biomaterials and Regenerative Medicine
来源：
Clinical Epigenetics | 2022年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 32 条
  • [21] Proline-directed yeast and human MAP kinases phosphorylate the Dot1p/DOT1L histone H3K79 methyltransferase
    Separovich, Ryan J.
    Karakatsanis, Nicola M.
    Gao, Kelley
    Fuh, David
    Hamey, Joshua J.
    Wilkins, Marc R.
    FEBS JOURNAL, 2024, 291 (12) : 2590 - 2614
  • [22] Hesperetin promotes DOT1L degradation and reduces histone H3K79 methylation to inhibit gastric cancer metastasis
    Wang, Si-wei
    Sheng, Hao
    Zheng, Fang
    Zhang, Feng
    PHYTOMEDICINE, 2021, 84
  • [23] Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
    L Chen
    A J Deshpande
    D Banka
    K M Bernt
    S Dias
    C Buske
    E J Olhava
    S R Daigle
    V M Richon
    R M Pollock
    S A Armstrong
    Leukemia, 2013, 27 : 813 - 822
  • [24] Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
    Chen, L.
    Deshpande, A. J.
    Banka, D.
    Bernt, K. M.
    Dias, S.
    Buske, C.
    Olhava, E. J.
    Daigle, S. R.
    Richon, V. M.
    Pollock, R. M.
    Armstrong, S. A.
    LEUKEMIA, 2013, 27 (04) : 813 - 822
  • [25] Abrogation of MLL-AF10 and CALM-AF10 Mediated Transformation Through Genetic Inactivation or Pharmacological Inhibition of the H3K79 Methyltransferase DOT1L
    Chen, Liying
    Deshpande, Aniruddha J.
    Banka, Deepti
    Kathrin, Bernt
    Dias, Stuart
    Buske, Christian
    Olhava, Edward J.
    Daigle, Scott R.
    Richon, Victoria M.
    Pollock, Roy M.
    Armstrong, Scott A.
    BLOOD, 2012, 120 (21)
  • [26] Human histone H3K79 methyltransferase DOT1L protein binds actively transcribing RNA polymerase II to regulate gene expression (vol 287, pg 39698, 2012)
    Kim, Seung-Kyoon
    Jung, Inkyung
    Lee, Hosuk
    Kang, Keunsoo
    Kim, Mirang
    Jeong, Kwiwan
    Kwon, Chang Seob
    Han, Yong-Mahn
    Kim, Yong Sung
    Kim, Dongsup
    Lee, Daeyoup
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (01) : 295 - 295
  • [27] DOT1L Epigenetically Induces the Expression Level of FoxM1 through H3K79me2 and Affects the Malignant Behaviors of Head and Neck Squamous Cell Carcinoma Cells
    Du, Huanle
    Zhang, Lin
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (02) : 101 - 108
  • [28] DOT1L interaction partner AF10 controls patterning of H3K79 methylation and RNA polymerase II to maintain cell identity
    Wille, Coral K.
    Neumann, Edwin N.
    Deshpande, Aniruddha J.
    Sridharan, Rupa
    STEM CELL REPORTS, 2023, 18 (12): : 2451 - 2463
  • [29] Hesperetin promotes DOT1L degradation and reduces histone H3K79 methylation to inhibit gastric cancer metastasis (vol 84,153499,2021)
    Wang, Si-Wei
    Sheng, Hao
    Zheng, Fang
    Zhang, Feng
    PHYTOMEDICINE, 2025, 136
  • [30] Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases
    Wakeman, Timothy P.
    Wang, Qinhong
    Feng, Junjie
    Wang, Xiao-Fan
    EMBO JOURNAL, 2012, 31 (09): : 2169 - 2181
1234